Examining the link between ovarian function and serum biomarkers
Official title: Study on the Correlation Between Ovarian Function and Serum Biomarkers
Run by Dongzhimen Hospital, Beijing · NCT06096766 · Data updated 2026-11-12
This study is trying to see how blood markers differ between healthy women and those with ovarian issues to better understand their connection.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 35 (estimated) |
| Sponsor | Dongzhimen Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | October 25, 2023 |
| Main results expected | November 11, 2025 |
| Study ends | November 11, 2025 |
| Registry record updated | December 9, 2024 |
| Trial ID | NCT06096766 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include women aged 18-45 with either normal ovarian function or diagnosed conditions like diminished ovarian reserve or premature ovarian insufficiency.
✕Probably not a fit
Patients with congenital gonadal abnormalities or those who have undergone ovarian surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify differences in serum biomarkers between women with normal ovarian function and those with conditions like premature ovarian insufficiency and diminished ovarian reserve. Participants will include healthy women and those diagnosed with these conditions, aged 18-45. Blood samples will be collected to measure levels of various biomarkers, including copper ions, ceruloplasmin, and malondialdehyde. The findings may help in understanding the relationship between ovarian function and these serum biomarkers.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools for assessing ovarian health in women.
How similar studies have gone: While there have been studies on ovarian function and biomarkers, this specific correlation is less explored, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. The selection criteria for healthy individuals are follows.
* women aged 18-45.
* Basic FSH\<10IU/L, and AMH is within the normal range.
* Regular menstruation.
* Agree and sign an informed consent form.
2. The selection criteria for DOR patients are follows.
* women aged 18-45.
* For two consecutive menstrual cycles, 25 ≥ basal FSH ≥ 10IU/L or AMH\<1.1ng/ml.
* Agree and sign an informed consent form.
3. Selection criteria for POI patients are follows.
* 18 ≤ females aged \<40 years old.
* Two consecutive menstrual cycles with basal FSH\>25IU/L or AMH\<1.1ng/ml.
* Agree and sign an informed consent form.
Exclusion Criteria:
1. Patients with congenital gonadal developmental abnormalities or a family history similar to "early menopause".
2. Patients with acquired organic lesions or decreased ovarian function caused by ovarian surgery.
3. Patients who have undergone artificial cycle therapy with Western medicine or other endocrine treatments within the past three months.
4. Patients with severe primary diseases and mental disorders such as crdiovascular, cerebrovascular, liver, kidney, and hematopoietic system.
5. Patients during lactation or pregnancy.
6. Patients who are allergic to the drugs used in this study or have a history of allergic reactions to traditional Chinese medicine.
Those who meet any of the above 5 criteria for DOR and POI will be excluded and not included in this study. The exclusion criteria for healthy subjects are as (1), (3), (4), and (5).
Where it's running
-
Dongzhimen Hospital, Beijing University of Chinese Medicine
Beijing, China Recruiting
Study contacts
- Principal investigator: Ke Xu, Master — Dongzhimen Hospital of Beijing University of Chinese Medicine
- Study coordinator: Yun Shi, PhD
- Email: zysyun@163.com
- Phone: 13717926522
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Autologous Hair Follicle Secretome + PRP for POI
This pilot study tests whether a patient’s own hair follicle secretome combined with their own platelet-rich plasma can improve ovarian function in women with premature ovarian insufficiency.
-
Aquatic power training dosing strategies and creatine in older adults
This trial tests whether different aquatic power training dosing methods and creatine supplementation help improve function in community-dwelling adults aged 60 and older.
-
Intergenerational Interaction Program for Nursing Home Residents and Nursing Students
A 6-week program pairs nursing home residents with nursing students to see if weekly joint activities can increase joy and reduce loneliness for older adults and lessen ageism in students.
-
Supplemental Mobility for older adults in skilled nursing facilities
This pilot tests whether adding a mobility aide to support walking and transfers alongside regular rehab helps older adults in SNFs after hospitalization see more daily activity and safer mobility.
-
G-CSF for DOR in women undergoing IVF
This trial tests whether G-CSF shots can improve IVF outcomes for women with diminished ovarian reserve.
-
Smart Voice Platform to Support Quality of Life for Community-Living Older Adults
A smart voice platform is tested to see if it improves quality of life and healthy aging for older adults living in the community.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.